BioLineRx (BLRX) Free Cash Flow (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -51.95% |
| Sep 30, 2025 | -1,089.83% |
| Jun 30, 2025 | 93.17% |
| Mar 31, 2025 | 69.93% |
| Dec 31, 2024 | 12.31% |
| Sep 30, 2024 | 13.07% |
| Jun 30, 2024 | 19.71% |
| Mar 31, 2024 | -381.15% |
| Dec 31, 2023 | 150.58% |
| Sep 30, 2023 | -2.96% |
| Jun 30, 2023 | -20.43% |
| Mar 31, 2023 | -41.91% |
| Dec 31, 2022 | 35.11% |
| Sep 30, 2022 | -38.83% |
| Jun 30, 2022 | -12.16% |
| Mar 31, 2022 | -2.33% |
| Dec 31, 2021 | -8.47% |
| Sep 30, 2021 | 26.33% |
| Jun 30, 2021 | -9.65% |
| Mar 31, 2021 | -14.30% |
| Dec 31, 2020 | 0.69% |
| Sep 30, 2020 | 1.69% |
| Jun 30, 2020 | 17.41% |
| Mar 31, 2020 | -24.39% |
| Dec 31, 2019 | 12.18% |
| Sep 30, 2019 | 3.97% |
| Jun 30, 2019 | -39.90% |
| Mar 31, 2019 | 8.98% |
| Dec 31, 2018 | 16.09% |
| Sep 30, 2018 | 3.22% |
| Jun 30, 2018 | 8.03% |
| Mar 31, 2018 | -10.80% |
| Dec 31, 2017 | 1.66% |
| Sep 30, 2017 | -48.70% |
| Jun 30, 2017 | -11.21% |
| Mar 31, 2017 | 10.70% |
| Dec 31, 2016 | -40.74% |
| Sep 30, 2016 | 7.82% |
| Jun 30, 2016 | 20.06% |
| Mar 31, 2016 | -36.22% |
| Dec 31, 2015 | -0.54% |
| Sep 30, 2015 | -31.92% |
| Jun 30, 2015 | 32.51% |
| Mar 31, 2015 | 30.01% |
| Dec 31, 2014 | -49.31% |
| Sep 30, 2014 | 26.16% |
| Jun 30, 2014 | -28.62% |
| Mar 31, 2014 | 9.30% |
| Dec 31, 2013 | 14.40% |
| Sep 30, 2013 | 30.50% |
| Jun 30, 2013 | -18.06% |